ImmunoGen Inc.

NASDAQ: IMGN · Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM

ImmunoGen Revenue

ImmunoGen reported an annual revenue of $108.78M, reflecting a 55.72% growth. For the quarter ending September 30, 2023, ImmunoGen generated $113.42M in revenue.
Revenue (ttm)
108.78M
Revenue Growth
55.72%
Price / Sales Ratio
11.56
Revenue / Employee
392.71K
Employees
277
Market Cap
8.73B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.